S

Selvas Healthcare Inc
KOSDAQ:208370

Watchlist Manager
Selvas Healthcare Inc
KOSDAQ:208370
Watchlist
Price: 5 250 KRW -1.87% Market Closed
Market Cap: ₩135.1B

Wall Street
Price Targets

Price Targets Summary
Selvas Healthcare Inc

There are no price targets for Selvas Healthcare Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Selvas Healthcare Inc Competitors:
Price Targets
TEL
TE Connectivity Ltd
14% Upside
PHUN
Phunware Inc
249% Upside
CBAN
Colony Bankcorp Inc
12% Upside

Revenue
Forecast

N/A
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Selvas Healthcare Inc's revenue for the next 8 years is -2%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

39% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
39% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for Selvas Healthcare Inc's net income is 39%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Selvas Healthcare Inc's stock price target?
Not Available

Selvas Healthcare Inc doesn't have any price targets made by Wall Street professionals.

What is Selvas Healthcare Inc's Revenue forecast?
Projected CAGR
-2%

The compound annual growth rate of Selvas Healthcare Inc's revenue for the next 8 years is -2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett